Veterinary DNA Testing Market Size & Growth Forecast 2027–2036, By Segments (Animal, Test, End Use, Sample), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 23664| Published Date: Nov-2026| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Veterinary DNA Testing Market size stood at USD 554.16 million in 2026 and is predicted to grow at a 10.82% CAGR from 2027 to 2036, attaining USD 1.55 billion by 2036. The industry revenue for 2027 is assessed at USD 606.03 million.

Base Year Value (2026)
USD 554.16 million
CAGR (2027-2036)
10.82%
Forecast Year Value (2036)
USD 1.55 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Veterinary DNA Testing Market Intelligence Snapshot

Regional Market Dynamics

  • North America held 43.2% market share in 2026, supported by advanced veterinary healthcare, established laboratory capabilities, growing animal genetics awareness, and demand for accurate genetic and diagnostic information.
  • Asia Pacific is the fastest-growing region, driven by improving veterinary infrastructure, rising animal health awareness, and greater use of genetic testing for disease screening, breeding decisions, and preventive care.

Segment Momentum

  • Dogs represented 64.32% of the market in 2026, supported by widespread ownership and growing interest in breed identification, hereditary conditions, ancestry, and preventive healthcare that helps owners and veterinarians make informed care decisions.
  • Breed profile testing accounted for 43.88% of the market in 2026 and is also the fastest-growing test segment, driven by interest in genetic ancestry, breed composition, personalized pet care, and responsible breeding.

Market Expansion Drivers

  • Increasing demand for genetic testing in veterinary care.
  • Advancements in DNA testing technologies for animals.
  • Regulatory emphasis on animal health and traceability.

Leading Market Participants

  • Major players in the veterinary DNA testing market include Mars Petcare (USA), Zoetis (USA), Neogen (USA), IDEXX Laboratories (USA), Orivet Genetic Pet Care (Australia), Wisdom Panel (USA), Basepaws (USA), DNA My Dog (Canada), Embark Veterinary (USA), Genoscoper Laboratories (Finland).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 554.16 million
  • 2027 Estimated Market Size: USD 606.03 million
  • Projected Market Size: USD 1.55 billion by 2036
  • Growth Forecast: 10.82% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Animal (Dogs) | Test (Breed Profile) | End Use (Veterinarians & Researchers) | Sample (Saliva)
  • Emerging Opportunity Segment: Animal (Dogs) | Test (Breed Profile) | End Use (Veterinarians & Researchers) | Sample (Saliva)
Market Dynamics

Market Growth Drivers and Industry Trends

Increasing demand for genetic testing in veterinary care

Increasing demand for genetic testing in veterinary care is driving adoption of veterinary DNA testing for disease screening, breed identification, inherited condition assessment, and personalized animal healthcare. Veterinarians and animal owners are increasingly seeking genetic information to support early identification of hereditary risks and enable more informed decisions regarding treatment, breeding, and preventive care. DNA testing also provides valuable insights into an animal's genetic characteristics that may not be identified through conventional clinical assessments. Furthermore, growing awareness of preventive veterinary medicine and the importance of early disease management is encouraging broader integration of genetic testing into routine animal healthcare practices.

Advancements in DNA testing technologies for animals

Advancements in DNA testing technologies for animals are improving the accessibility, accuracy, and application range of veterinary genetic testing. Developments in molecular analysis, sequencing techniques, sample processing, and bioinformatics are enabling more comprehensive evaluation of animal genetic profiles. These technologies support the identification of inherited disorders, genetic traits, parentage, and breed characteristics across a broader range of animal species. Increasing availability of user-friendly testing processes is also making genetic analysis more accessible to veterinary professionals, breeders, researchers, and animal owners. As testing capabilities continue to expand, DNA-based insights are becoming increasingly relevant to preventive healthcare, breeding management, and animal wellness programs.

Regulatory emphasis on animal health and traceability

Regulatory emphasis on animal health and traceability is supporting the adoption of veterinary DNA testing across livestock management, breeding programs, veterinary services, and animal identification applications. Genetic testing can provide reliable information for verifying parentage, maintaining breeding records, identifying animals, and supporting disease-control initiatives. Increasing attention to animal welfare and health monitoring is encouraging stakeholders to adopt more robust methods for tracking genetic and health-related characteristics. In addition, traceability requirements across animal production systems are creating demand for technologies that improve record accuracy and support transparent management practices. These regulatory and industry requirements are strengthening the role of DNA testing in modern animal health and management systems.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing demand for genetic testing in veterinary care 4% Short term (≤ 2 yrs) North America; Europe; Spillover: Asia Pacific Medium Fast
Advancements in DNA testing technologies for animals 3% Medium term (2–5 yrs) North America; Europe; Spillover: Asia Pacific Low Moderate
Regulatory emphasis on animal health and traceability 2% Long term (5+ yrs) North America; Europe; Spillover: Asia Pacific Medium Moderate

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Veterinary DNA Testing Market
Largest Region
North America
43.2% Market Share in 2026

North America (Largest Region)

North America dominated the veterinary DNA testing market with the largest share of 43.2% in 2026. The North American veterinary DNA testing market is supported by advanced veterinary healthcare infrastructure, growing awareness of animal genetics, and increasing demand for accurate genetic and diagnostic information. Veterinary DNA testing is increasingly used for disease screening, genetic trait identification, breed determination, and reproductive management in companion and livestock animals. Growing interest in preventive animal healthcare and personalized veterinary services is encouraging wider adoption of genetic testing technologies. In addition, advanced laboratory capabilities, increasing awareness among animal owners and veterinary professionals, and continued development of molecular diagnostic technologies are supporting market growth across the region.

Asia Pacific (Fastest-Growing Region)

The veterinary DNA testing market in Asia Pacific is expanding at the fastest pace, propelled by improving veterinary healthcare infrastructure, rising awareness of animal health, and growing adoption of genetic testing technologies. Increasing demand for improved livestock management and companion animal healthcare is creating opportunities for veterinary DNA testing services. Genetic testing can support disease identification, breeding decisions, and the management of inherited traits, making it increasingly relevant across animal healthcare and agricultural applications. In addition, expanding veterinary services, technological advancements, and growing awareness of preventive animal healthcare are supporting market development. The increasing use of modern diagnostic approaches is expected to further strengthen adoption across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation HubiScaleNascentDeveloping Advanced
Cost-Sensitive RegioniScaleLowMedium High
Regulatory EnvironmentiScaleRestrictiveNeutral Supportive
Demand DriversiScaleWeakModerate Strong
Development StageiScaleEmergingDeveloping Developed
Adoption RateiScaleLowMedium High
New Entrants / StartupsiScaleSparseModerate Dense
Macro IndicatorsiScaleWeakStable Strong
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Precision Veterinary Diagnostics

The U.S. veterinary DNA testing market is expanding its role across inherited-disease screening, breed identification, and personalized veterinary care. Commercial priorities include clinically useful test panels, rapid laboratory workflows, clear interpretation for veterinarians, and integration of genetic findings into broader diagnostic and preventive-care decisions.

Germany 🇩🇪

Genomic Veterinary Screening

Germany's market emphasizes structured genetic screening for inherited disorders, breeding decisions, and animal health management. Testing providers are prioritizing validated assays, reliable laboratory quality, transparent reporting, and integration with veterinary practices and breeding organizations that require actionable genetic information.

Japan 🇯🇵

Companion Animal Genetics

Japan's veterinary DNA testing market is increasingly oriented toward companion-animal health and responsible breeding. Providers are focusing on accessible genetic screening, hereditary-disease detection, breed-related insights, and straightforward reports that help veterinarians and pet owners translate genomic information into practical care decisions.

South Korea 🇰🇷

Advanced Pet Genomics

South Korea's market is closely tied to sophisticated companion-animal care and growing interest in genetic information. Commercial priorities include comprehensive testing panels, digital result delivery, hereditary-condition screening, and services that connect DNA insights with preventive veterinary care and breeding management.

France 🇫🇷

Responsible Breeding Genetics

France's veterinary DNA testing market has strong relevance to responsible breeding and hereditary-disease management. Testing providers are emphasizing validated genetic markers, traceable results, breed-specific screening, and practical interpretation that supports breeders and veterinarians in making informed health and breeding decisions.

Italy 🇮🇹

Breed Health Screening

Italy's market benefits from the role of genetic testing in pedigree management, breeding programs, and companion-animal health. Suppliers are prioritizing breed-relevant hereditary screening, accessible testing workflows, reliable documentation, and reports that provide actionable information for veterinarians, breeders, and owners.

Veterinary DNA Testing Market Share (%), by Animal, 2026

64.32%
Dogs
Cats
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Animal Segment Analysis: Dogs (Largest & Fastest-Growing Segment)

The dogs segment captured a 64.32% market share of the veterinary DNA testing market in 2026 and is also projected to be the fastest-growing animal segment, supported by widespread dog ownership and increasing interest in genetic information for companion animals. DNA testing is increasingly used to identify breed composition, hereditary traits, genetic predispositions, and ancestry, enabling owners and veterinary professionals to obtain more detailed information about individual animals. Growing awareness of preventive veterinary care is encouraging the use of genetic testing alongside routine health assessments, particularly for identifying inherited conditions and supporting more informed breeding decisions. The expanding availability of direct-to-consumer and veterinary-supported testing services is also improving accessibility. In addition, rising expenditure on companion animal healthcare is strengthening demand for advanced diagnostic and genetic tools. Greater interest in personalized pet care, responsible breeding, and early identification of inherited risks is expected to sustain the strong adoption of veterinary DNA testing for dogs.

Test Segment Analysis: Breed Profile (Largest & Fastest-Growing Segment)

The breed profile segment accounted for a 43.88% market share in 2026, standing as the largest and fastest-growing test segment in the veterinary DNA testing market, reflecting strong consumer and veterinary interest in identifying the genetic ancestry and breed composition of animals. Breed profiling provides insights into an animal's genetic background and can help owners better understand physical characteristics, behavioral tendencies, and potential breed-associated health considerations. Increasing adoption of mixed-breed dogs and growing curiosity about lineage are supporting demand for accessible genetic identification services. Veterinary professionals can also use breed information as a supplementary consideration when evaluating hereditary disease risks and developing appropriate care strategies. Advances in DNA analysis have made breed identification more convenient and accessible, encouraging broader adoption among pet owners. Rising interest in personalized pet ownership, responsible breeding, and preventive healthcare is expected to further strengthen demand for breed profile testing.

End Use Segment Analysis: Veterinarians & Researchers (Largest & Fastest-Growing Segment)

In 2026, the veterinarians and researchers segment accounted for a 43.31% share of the veterinary DNA testing market and is also projected to be the fastest-growing end-use segment, driven by the expanding role of genetic information in veterinary diagnostics, animal health management, and scientific research. Veterinarians can use DNA testing to investigate hereditary conditions, support diagnostic evaluations, inform breeding decisions, and develop more individualized approaches to animal care. Researchers rely on genetic testing to study disease susceptibility, inherited traits, population genetics, and animal health patterns, creating demand across both clinical and research settings. Increasing emphasis on preventive veterinary medicine is encouraging broader integration of genetic information into routine animal healthcare. At the same time, advances in molecular testing technologies are improving the accuracy and accessibility of veterinary genetic analysis. Growing research into inherited diseases and animal genomics is expected to further expand the use of DNA testing among veterinary professionals and research institutions.

Segment Sub-Segment Largest Segment Fastest Growing
Animal Dogs, Cats, Others Dogs Dogs
Test Breed Profile, Genetic Diseases, Health and Wellness Breed Profile Breed Profile
End Use Veterinarians & Researchers, Animal Breeders, Animal Owners Veterinarians & Researchers Veterinarians & Researchers
Sample Blood, Saliva, Fecal, Others Saliva Saliva
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Analyst Perspective:

Strategic differentiation in veterinary DNA testing centers on balancing assay versatility with reporting accuracy across distinct distribution channels. Providers are expanding portfolios beyond companion animal breed profiling to encompass complex genetic health screening and multi-species panels for livestock and equine management. Direct-to-consumer models drive volume through accessible digital reports, whereas veterinary clinic channels emphasize professional diagnostic integration and clinical guidance. Regardless of the distribution model, long-term commercial credibility relies on maintaining rapid turnaround times and high sample processing reliability without compromising genetic accuracy, enabling breeders, veterinarians, and pet owners to make informed medical and breeding decisions.

Major players in the veterinary DNA testing market:

  1. Mars Petcare (USA)
  2. Zoetis (USA)
  3. Neogen (USA)
  4. IDEXX Laboratories (USA)
  5. Orivet Genetic Pet Care (Australia)
  6. Wisdom Panel (USA)
  7. Basepaws (USA)
  8. DNA My Dog (Canada)
  9. Embark Veterinary (USA)
  10. Genoscoper Laboratories (Finland)

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Mars Petcare (USA)
Zoetis (USA)
Neogen (USA)
IDEXX Laboratories (USA)
Orivet Genetic Pet Care (Australia)
Wisdom Panel (USA)
Basepaws (USA)
DNA My Dog (Canada)
Embark Veterinary (USA)
Genoscoper Laboratories (Finland)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Veterinary DNA Testing Market — Custom Segments

Segment Sub-Segment
Testing Technology PCR-Based Testing, Microarray-Based Testing, Next-Generation Sequencing, Sanger Sequencing
Laboratory Type Veterinary Diagnostic Laboratories, Specialized Genetic Testing Laboratories, Academic & Research Laboratories, Commercial Reference Laboratories
Pricing Model Per-Test Pricing, Test Panel Pricing, Subscription-Based Testing, Contract-Based Testing

Veterinary DNA Testing Market — Custom TOC

Custom Chapter Chapter Details
Veterinary Diagnostic Adoption Pathways
  • Adoption Drivers Across Veterinary Care Settings
  • Diagnostic Workflow Integration and Clinical Use Cases
  • Veterinary Professional Awareness and Adoption Barriers
  • Emerging Testing Applications
Pet Genetics Consumer Segmentation
  • Consumer Needs and Genetic Testing Motivations
  • Pet Owner Attitudes Toward Preventive Genetic Insights
  • Breed, Health and Trait Testing Preferences
  • Consumer Engagement and Retention Opportunities
Genetic Data Privacy & Ownership Landscape
  • Veterinary Genetic Data Governance Frameworks
  • Data Ownership, Consent and Sharing Practices
  • Privacy Requirements Across Testing and Digital Platforms
  • Commercial Implications of Genetic Data Management

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

What is the overall size of the veterinary DNA testing market?

In 2027, the market for veterinary DNA testing is worth approximately USD 606.03 million.

What is the projected value of the veterinary DNA testing industry by 2036?

Veterinary DNA Testing Market size stood at USD 554.16 million in 2026 and is predicted to grow at a 10.82% CAGR from 2027 to 2036, attaining USD 1.55 billion by 2036.

How is preventive veterinary care increasing adoption of DNA testing?

Greater focus on early disease identification and preventive animal healthcare is encouraging veterinarians and owners to use DNA testing for hereditary risk assessment, treatment decisions, breeding management, and broader animal wellness programs.

How are traceability requirements expanding the commercial role of veterinary DNA testing?

Animal health and traceability requirements are increasing demand for genetic verification, parentage records, identification, and disease-control support, strengthening DNA testing’s role in structured breeding and modern animal management systems.

Why do dogs account for the largest share of the veterinary DNA testing market?

Dogs represented 64.32% of the market in 2026, supported by widespread ownership and growing interest in breed identification, hereditary conditions, ancestry, and preventive healthcare that helps owners and veterinarians make informed care decisions.

How is demand for breed profile testing shaping the veterinary DNA testing market?

Breed profile testing accounted for 43.88% of the market in 2026 and is also the fastest-growing test segment, driven by interest in genetic ancestry, breed composition, personalized pet care, and responsible breeding.

Why does North America lead the veterinary DNA testing market?

North America held 43.2% market share in 2026, supported by advanced veterinary healthcare, established laboratory capabilities, growing animal genetics awareness, and demand for accurate genetic and diagnostic information.

How is Asia Pacific accelerating veterinary DNA testing market growth?

Asia Pacific is the fastest-growing region, driven by improving veterinary infrastructure, rising animal health awareness, and greater use of genetic testing for disease screening, breeding decisions, and preventive care.

Which companies are driving growth in the veterinary DNA testing landscape?

Major players in the veterinary DNA testing market include Mars Petcare (USA), Zoetis (USA), Neogen (USA), IDEXX Laboratories (USA), Orivet Genetic Pet Care (Australia), Wisdom Panel (USA), Basepaws (USA), DNA My Dog (Canada), Embark Veterinary (USA), Genoscoper Laboratories (Finland).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →